Analyst Price Target is $14.20
▲ +326.94% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Orchestra BioMed in the last 3 months. The average price target is $14.20, with a high forecast of $20.00 and a low forecast of $12.00. The average price target represents a 326.94% upside from the last price of $3.33.
Current Consensus is
Buy
The current consensus among 5 contributing investment analysts is to buy stock in Orchestra BioMed. This Buy consensus rating has held steady for over two years.